In recent breast cancer studies, Ursolic acid (UA) was found to enable transcription factor EB (TFEB) nuclear entry in a partial mammalian target of rapamycin (mTOR)-dependent manner and prevent its ubiquitination. This evidence concerns the gene MTOR and breast cancer.